This issue features a look at adapting to scientific meeting climate change and coverage from the 15th International Myeloma Workshop.
This special issue of ASH Clinical News features updates in the world of multiple myeloma, including treatment options, advancements in understanding the disease, and looking ahead to the landscape of care.
This issue features coverage from the ASH Meeting on Hematologic Malignancies that took place in Chicago, IL. Our feature on big data reveals its potential to revolutionize healthcare, and our Editor's Corner gives an in-depth look at putting together a presentation for the upcoming ASH Annual Meeting.
In this issue, we look at the problem of physician burnout, follow a day in the life of a hem/onc APP, and examine the work-life spectrum.
This month, we take a behind-the-scenes look at guideline development, debate the length of anticoagulation for cancer-associated thrombosis, and report on the latest hematologic research from the American Society of Clinical Oncology annual meeting and the International Society on Thrombosis and Haemostasis 2015 Congress.
This month, we uncover the potential pitfalls of precision medicine, report on the latest hematologic research from the American Society of Clinical Oncology annual meeting and European Hematology Association Congress, and more.
This month, we take an in-depth look at the work that hematology advocates are doing, the latest research from Blood, and the latest hematology/oncology news.
This issue features a look at new tactics for fighting the cancer drug pricing bloat, a debate on fludarabine in CLL, a report from ASH’s Sickle Cell Disease Summit, and more.
This issue features a look at the ACA’s out-of-pocket limit, reports from the IOM’s Pediatric Oncology Workshop, tips for improving your presentations, and more.
This issue features a debate of rituximab versus splenectomy in ITP patients, a look at novel oral anticoagulants taking warfarin’s place, mentoring advice from a fellowship program director, and more.